Haemonetics Corporation (HAE) saw a big move in the last trading session, as the company’s shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $32.00 to $33.82 in the past one-month time frame.
The company, engaged in the design, manufacture and worldwide marketing of automated blood processing systems, has not seen any estimate revision over the past month, and its current year earnings consensus hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, especially on earnings estimates following the recent slump.
HAE currently holds a Zacks Rank #4 (Sell).
Investors interested in the Medical Products industry may consider better-ranked stocks like Mead Johnson Nutrition Company (MJN), William Demant Holding A/S (WILYY) and Venaxis, Inc. (APPY). Each of these stocks carries a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment